Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      Homescience news

      science news

      atai Life Sciences Announces First Subject Dosed in Phase 1 Trial of Buccal and IV VLS-01, a Synthetic Form of DMT
      Other

      atai Life Sciences Announces First Subject Dosed in Phase 1 Trial of Buccal and IV VLS-01, a Synthetic Form of DMT

      October 5, 2022
      Bngo Stock Rises as Optical Genome Mapping Is Better at Detecting Mutations
      Investing News

      Bngo Stock Rises as Optical Genome Mapping Is Better at Detecting Mutations

      October 5, 2022
      Abbvie Stock Recovers Some of Its Previous Losses When Svb Leerink Retracts Some of Its Guiding Statements.
      Investing News

      Abbvie Stock Recovers Some of Its Previous Losses When Svb Leerink Retracts Some of Its Guiding Statements.

      September 30, 2022
      Jnj Stock Rises as Kenvue Is the Name Given to Its Consumer Health Offshoot
      Investing News

      Jnj Stock Rises as Kenvue Is the Name Given to Its Consumer Health Offshoot

      September 28, 2022
      Moderna Stock Stayed Flat as It Asked FDA to Approve Enhanced COVID Boosters for Kids.
      Investing News

      Moderna Stock Stayed Flat as It Asked FDA to Approve Enhanced COVID Boosters for Kids.

      September 25, 2022
      Novavax Stock Drops As JPMorgan Cuts Its Long-Term Prognosis
      Trading Tips

      Novavax Stock Drops As JPMorgan Cuts Its Long-Term Prognosis

      September 22, 2022
      Pfizer Stock Rises, Company to Provide Global Fund With up to 6 Million Paxlovid Therapy Courses to Treat COVID
      Investing News

      Pfizer Stock Rises, Company to Provide Global Fund With up to 6 Million Paxlovid Therapy Courses to Treat COVID

      September 22, 2022
      What Is the Situation With Cassava Sciences Stock?
      Investing News

      What Is the Situation With Cassava Sciences Stock?

      September 22, 2022
      Could Pfizer Stock Be Misjudged by the Market Despite Its Strong Fundamentals?
      Trading Tips

      Could Pfizer Stock Be Misjudged by the Market Despite Its Strong Fundamentals?

      September 21, 2022
      AbbVie Stock Valuation Is Appealing Due to Humira Challenges
      Trading Tips

      AbbVie Stock Valuation Is Appealing Due to Humira Challenges

      September 19, 2022
      « 1 … 6 7 8 9 10 … 16 »

       

      LATEST NEWS

      • Investing News JPMorgan Q4 2025 Earnings Overview
      • Investing News As Netflix Drops 33%, Is NFLX Stock a Buy Ahead of Q4?
      • Investing News Will AAPL Stock Rebound in 2026?
      • Investing News Retail’s 2025 Holiday Growth
      • Investing News Goldman Sachs Earnings Lead Q1 Reports

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026